bioRxivBiochemistry
Stitched peptides as potential cell permeable inhibitors of oncogenic DAXX protein
C. Jelinska, S. Kannan, F. R. Winnerdy, Y. Frosi, S. R. Ramlan, R. Lakshminarayanan, C. J. Brown, A.-T. Phan, D. Rhodes, C. S. Verma
Abstract
The death domain associated protein 6 (DAXX) is frequently upregulated in a number of common cancers where its suppression has been linked to reduced tumour progression. As a master regulator protein, with >70 reported protein interaction partners, the role of DAXX in its oncogenecity remains unclear. We designed and developed a set of novel stapled/stitched peptides that target a surface on the N-terminal helical bundle domain of DAXX which is the anchor-point for binding to multiple interaction partners (including Rassf1C, P53, Mdm2 and ATRX) and also for the auto regulation of the DAXX N-terminal SUMO interaction motif (SIM). We demonstrate that these peptides bind to and inhibit DAXX with an affinity higher than those reported for the known interaction partners and release the auto-inhibited SIM for interaction with SUMO-1. NanoBret assays show that the peptides enter cells and that their intracellular concentrations remain at nanomolar levels even after 24 hours, without causing membrane perturbation. Together our data suggest that these peptides are both tools for probing the molecular interactions of DAXX and potential precursors to the development of therapeutics.
- organism: human
- assay: protein structure
- research focus: drug response / drug discovery
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Macrocyclization of an all-D linear peptide improves target affinity and imparts cellular activity: A novel stapled α-helical peptide modality
S. Kannan, P. G. A. Aronica, … A. Partridge·bioRxiv·Sep 12, 2019
- Discovery of high affinity and specificity stapled peptide Bcl-xL inhibitors using bacterial surface display
Marshall Case, Jordan Vinh, … Greg M. Thurber·bioRxiv·Dec 5, 2023
- Peptide-mediated inhibition of the transcriptional regulator Elongin BC induces apoptosis in cancer cells
S. Fischer, V. T. Trinh, … O. Vazquez·bioRxiv·Nov 4, 2022
- Engineering Stapled Peptide Inhibitors Reveals Design Principles for Targeting Talin-Induced Integrin Activation
Tong Gao, Elizaveta Belova, … Jinhua Wu·bioRxiv·Aug 31, 2026
- Computational design of Bax-inhibiting peptides
Tom Vlaar, Bernadette Mayer, … Ioana Mariuca Ilie·Materials AdvancesPeer-reviewed·Jan 1, 2025
- Global analysis of cancer cell responses to USP9X inhibition
Philipp Schenk, Shane M. Devine, … David Komander·The EMBO JournalPeer-reviewed·Apr 7, 2026